Letters to the Editor

Daratumumab combining with venetoclax, three-day multi-frequency decitabine, vincristine, dexamethasone (VDVD) as the salvage treatment of relapsed/refractory T-cell acute lymphoblastic leukemia

Department of Hematology, Handan Central Hospital, Handan, Hebei
Department of Hematology, The Second People's Hospital of Guiyang, Guiyang, Guizhou
Department of Hematology, People Hospital of XingTai, Xing Tai, Hebei
Department of Hematology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei
Department of Hematology, Handan Central Hospital, Handan, Hebei
Department of Hematology, Handan Central Hospital, Handan, Hebei
Department of Hematology, The Second People's Hospital of Guiyang, Guiyang, Guizhou
Department of Hematology, The Second People's Hospital of Guiyang, Guiyang, Guizhou
Department of Hematology, People Hospital of XingTai, Xing Tai, Hebei
Department of Hematology, People Hospital of XingTai, Xing Tai, Hebei
Department of Hematology, Tongliao People's Hospital, Tongliao, Neimenggu
Department of Hematology, Handan Central Hospital, Handan, Hebei
State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020
State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020
Haematologica Early view Jul 30, 2026 https://doi.org/10.3324/haematol.2026.301095